Trial
NCT04049175
Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Chiesi Farmaceutici S.p.A.
Collaborators
—
Condition
Asthma
Intervention
Treatment A
Why stopped
An interim analysis run by an independent data monitoring committee (DMC) to assess futility met the protocol-defined futility rules. The DMC recommended to stop the study for futility. The Sponsor issued a notification of early study termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-08